Bridging the Gap: Immune Checkpoint Inhibitor as an Option in the Management of Advanced and Recurrent Cervical Cancer in Sub-Saharan Africa-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Bridging the Gap: Immune Checkpoint Inhibitor as an Option in the Management of Advanced and Recurrent Cervical Cancer in Sub-Saharan Africa

Published:2024-09-10 Issue: Volume: Page:
ISSN:2168-8184
Container-title:Cureus
language:en
Short-container-title:

Author:

Okpalanwaka Izuchukwu F,Anazodo Francis I,Chike-Aliozor Zimuzor L,Ekweozor Chika,Ochie Kossy M,Oboh Onyeka F,Okonkwo Faustina C,Njoku Munachiso F

Publisher

Springer Science and Business Media LLC

Reference124 articles.

1. Cancer cervix: epidemiology and disease burden;Pimple S;Cytojournal,2022

2. Cancer statistics, 2023;Siegel RL;CA Cancer J Clin,2023

3. Global estimates of incidence and mortality of cervical cancer in 2020: a baseline analysis of the WHO Global Cervical Cancer Elimination Initiative;Singh D;Lancet Glob Health,2023

4. Global health equity: cancer care outcome disparities in high-, middle-, and low-income countries;de Souza JA;J Clin Oncol,2016

5. Regional and country-level trends in cervical cancer screening coverage in sub-Saharan Africa: a systematic analysis of population-based surveys (2000-2020);Yang L;PLoS Med,2023

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP